A phase 1/2, prospective, single arm study to investigate the Cell Pouch System of Islet transplantation for treatment of type 1 diabetes (T1D) in individuals with hypoglycemia unawareness.

Trial Profile

A phase 1/2, prospective, single arm study to investigate the Cell Pouch System of Islet transplantation for treatment of type 1 diabetes (T1D) in individuals with hypoglycemia unawareness.

Planning
Phase of Trial: Phase I/II

Latest Information Update: 15 Dec 2017

At a glance

  • Drugs Islet cell replacement therapy (Primary)
  • Indications Type 1 diabetes mellitus
  • Focus Adverse reactions
  • Sponsors Sernova Corp
  • Most Recent Events

    • 15 Dec 2017 New trial record
    • 11 Dec 2017 According to a Sernova media release, company has received US Food and Drug Administration (FDA) notice of allowance for its IND for a new human clinical trial with the Cell Pouch System (TM) (CPS) in the United States.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top